Use of certain glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly increased risk for new-onset rheumatoid arthritis (RA), particularly with shorte ...

Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to ...

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage ...

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat ...

In a study of heart health among adults living with type 2 diabetes (T2D), the use of GLP-1 receptor agonists (GLP-1 RAs) in combination with adherence to healthy lifestyle habits was linked with ...

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among patients of different ages, races, and starting weights, with women benefiting ...

Obesity shaped Anna Olson's earliest notions of herself, when she saw a photo and thought, "Oh, I look different than the other kids." Olson's obesity began in toddlerhood, ran in her family, and left ...

As millions of Americans take GLP‑1 medications like Ozempic, Wegovy and Mounjaro for weight loss or diabetes, doctors are noticing that some patients are developing previously unrecognized eating ...

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among patients of different ages, races, and starting weights, with women benefiting ...